Medications

How a novel drug pushes the HIV capsid to breaking point

Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral drug to treat human immunodeficiency virus (HIV) infections. Lenacapavir is the first drug available to patients ...

HIV & AIDS

New study reveals how HIV binds to our T cells

A new study reveals for the first time the steps through which human immunodeficiency virus (HIV) binds to the receptors on the membranes of T cells—white blood cells that fight infection. The finding could have implications ...

page 2 from 38